TGA Approval

25 March 2022

Sunrise gets Therapeutic Goods Administration approval for Sleep Apnea and Sleep Bruxism diagnosis.

Australia is a very mature market with some of the brightest sleep clinicians and researchers. We are excited to bring the latest diagnosis innovation to Australia to give everyone the opportunity for better sleep by first unlocking the sleep apnea diagnosis bottleneck,” said co-founder and CEO Laurent Martinot.